T Cell Phenotype and T Cell Receptor Repertoire in Patients with Major Depressive Disorder

Autor: Patas, Kostas, Willing, Anne, Demiralay, Cüneyt, Engler, Jan Broder, Lupu, Andreea, Ramien, Caren, Schäfer, Tobias, Gach, Christian, Stumm, Laura, Chan, Kenneth, Vignali, Marissa, Arck, Petra C., Friese, Manuel A., Pless, Ole, Wiedemann, Klaus, Agorastos, Agorastos, Gold, Stefan M.

Publikováno v: Frontiers in Immunology

While a link between inflammation and the development of neuropsychiatric disorders, including major depressive disorder (MDD) is supported by a growing body of evidence, little is known about the contribution of aberrant adaptive immunity in this co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::356802799cfc5cfa5a356964ff3d4d25
https://publica.fraunhofer.de/handle/publica/256667

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

T Cell Phenotype and T Cell Receptor Repertoire in Patients with Major Depressive Disorder

Autor: Patas, Kostas, Willing, Anne, Demiralay, Cüneyt, Engler, Jan Broder, Lupu, Andreea, Ramien, Caren, Schäfer, Tobias, Gach, Christian, Stumm, Laura, Chan, Kenneth, Vignali, Marissa, Arck, Petra C., Friese, Manuel A., Pless, Ole, Wiedemann, Klaus, Agorastos, Agorastos, Gold, Stefan M.

While a link between inflammation and the development of neuropsychiatric disorders, including major depressive disorder (MDD) is supported by a growing body of evidence, little is known about the contribution of aberrant adaptive immunity in this co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7bfd95f276a0ec99efef4826428484f8

T Cell Phenotype and T Cell Receptor Repertoire in Patients with Major Depressive Disorder.

Autor: Patas K; Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany., Willing A; Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany., Demiralay C; Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany., Engler JB; Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany., Lupu A; Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.; Immunomodulation Group, Cantacuzino National Research Institute, Bucharest, Romania., Ramien C; Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany., Schäfer T; Fraunhofer IME ScreeningPort, Hamburg, Germany., Gach C; Fraunhofer IME ScreeningPort, Hamburg, Germany., Stumm L; Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany., Chan K; Adaptive Biotechnologies, Seattle, WA, Unites States., Vignali M; Adaptive Biotechnologies, Seattle, WA, Unites States., Arck PC; Experimentelle Feto-Maternale Medizin, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany., Friese MA; Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany., Pless O; Fraunhofer IME ScreeningPort, Hamburg, Germany., Wiedemann K; Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany., Agorastos A; Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany., Gold SM; Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.; Charité - Universitätsmedizin Berlin, Humboldt Universität zu Berlin, Berlin Institute of Health (BIH), Klinik für Psychiatrie und Psychotherapie, Campus Benjamin Franklin (CBF), Berlin, Germany.

Publikováno v: Frontiers in immunology [Front Immunol] 2018 Feb 20; Vol. 9, pp. 291. Date of Electronic Publication: 2018 Feb 20 (Print Publication: 2018).